CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
  • About
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Rosemary Harrison Joins TCR Therapeutics as Chief Business and Strategy Officer

Rosemary Harrison Joins TCR...

Clinical Research Technology Leader RealTime Secures Growth Investment from LLR Partners

Clinical Research Technology Leader...

Catalyst Biosciences Announces Major Leadership Changes

Catalyst Biosciences Announces Major...

BetterLife- Carleton University Research Team Secures Funding form Mitacs

BetterLife- Carleton University...

ClearPoint Neuro Appoints Lynnette C. Fallon to Board of Directors

ClearPoint Neuro Appoints Lynnette C....

Marc Drimer, CPA, Joins the Board of Directors of Curative Biotechnology

Marc Drimer, CPA, Joins the Board of...

James Pekarsky Joins Gelteq as Chief Financial Officer

James Pekarsky Joins Gelteq as Chief...

BioStem Technologies Announces the Approval of Q Code for VENDAJE from CMS

BioStem Technologies Announces the...

Rosemary Harrison Joins TCR Therapeutics as Chief Business and Strategy Officer

Rosemary Harrison Joins TCR...

Clinical Research Technology Leader RealTime Secures Growth Investment from LLR Partners

Clinical Research Technology Leader...

Catalyst Biosciences Announces Major Leadership Changes

Catalyst Biosciences Announces Major...

BetterLife- Carleton University Research Team Secures Funding form Mitacs

BetterLife- Carleton University...

ClearPoint Neuro Appoints Lynnette C. Fallon to Board of Directors

ClearPoint Neuro Appoints Lynnette C....

Marc Drimer, CPA, Joins the Board of Directors of Curative Biotechnology

Marc Drimer, CPA, Joins the Board of...

James Pekarsky Joins Gelteq as Chief Financial Officer

James Pekarsky Joins Gelteq as Chief...

BioStem Technologies Announces the Approval of Q Code for VENDAJE from CMS

BioStem Technologies Announces the...

Merakris Therapeutics Partners with Miracles In Sight Eye Bank

Life Sciences Review Life Sciences Review | Thursday, July 29, 2021
Tweet

Merakris Therapeutics has signed an agreement with Miracles In Sight (MIS) to provide Opticyte Amniotic Ophthalmic Repair Grafts to MIS-affiliated eye doctors in three states.


FREMONT, CA: Merakris Therapeutics, based in Research Triangle Park, has signed an agreement with Miracles In Sight (MIS) to provide Opticyte Amniotic Ophthalmic Repair Grafts to MIS-affiliated eye doctors in three states.


One of the largest non-profit eye banks globally, MIS offers highly advanced corneal tissue for transplantation to restore, preserve, and improve vision. The North Carolina-based company Winston-Salem collaborates with worldwide innovators to test novel techniques and solutions that address emerging ophthalmic concerns. Through the Merakris collaboration, MIS is connected with more than 70 eye clinics in North and South Carolina and Texas, who will now have easy access to Opticyte.


The Opticyte Amniotic Ophthalmic Repair Grafts are a biological barrier that shields the eye's corneal surface while recovering and helps avoid scar tissue formation. 


The substance promotes cell adhesion and ingrowth, and it's frequently employed as an additional biological barrier in individuals with dry eye disease or other corneal abnormalities. The grafts, made from an amniotic membrane, come in several shapes and sizes to meet various surgical demands.


"We are excited to begin this new partnership with Miracles In Sight as we continue to grow through new additions to the Merakris family of products," said Chris Broderick, the company's CEO. "During the past year we have launched Opticyte through a variety of channels, ranging from business-to-business sales to strategic partnerships like this one. We know the MIS team well and we are eager to fully support their clinics across these three service areas."


"At Miracles in Sight, our mission is to support the restoration, preservation and enhancement of site,"  said Kristen McCoy, vice president of Surgical Applications. "This partnership aligns with our mission and allows us to expand our service options. We are excited to work with Merakris to make the Opticyte product available to our community of physicians."


Weekly Brief

loading
> <
  • DNA Sequencing 2022

    Top Vendors

    Current Issue
  • BioTech Startups 2022

    Top Vendors

    Current Issue
  • DNA Sequencing 2022

    Top Vendors

    Current Issue
  • BioTech Startups 2022

    Top Vendors

    Current Issue

Read Also

Role of Predictive Genomics in Sustainable Healthcare

Role of Predictive Genomics in Sustainable Healthcare

A Conversational AI Approach to Regulatory Intelligence

A Conversational AI Approach to Regulatory Intelligence

A rise in DNA Sequencing Market is expected in coming years

A rise in DNA Sequencing Market is expected in coming years

Omniabio Inc. Announces Private Investor

Omniabio Inc. Announces Private Investor
Data analysis for next-generation sequencing worth USD1.2 billion by 2026 - Cloud-based platforms emerging as preferred solutions

Data analysis for next-generation sequencing worth USD1.2 billion by 2026 - Cloud-based platforms emerging as preferred solutions

Lithuania's Vision to Become a Biotech Hub in Europe

Lithuania's Vision to Become a Biotech Hub in Europe

Bridging the Diversity Gap in Genomics

Bridging the Diversity Gap in Genomics

How does Biotechnology Provide Solutions to Human Needs?

How does Biotechnology Provide Solutions to Human Needs?
Loading...

Copyright © 2022 Life Science Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/merakris-therapeutics-partners-with-miracles-in-sight-eye-bank-nwid-474.html